ارتباط اختلال عملکرد جنسی با نوع درمان در زنان مبتلا به سرطان های دستگاه تناسلی و پستان

نوع مقاله: اصیل پژوهشی

نویسندگان

1 کارشناس ارشد مامایی، مرکز تحقیقات مراقبت های پرستاری و مامایی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران.

2 کارشناس ارشد مامایی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران.

3 دانشجوی کارشناس مامایی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران.

چکیده

مقدمه: اختلال عملکرد جنسی به مفهوم اختلال در تمایل جنسی و تغییرات روانی اجتماعی است که بر روی چرخه پاسخ جنسی تأثیر گذاشته و باعث ایجاد استرس و مشکلات بین فردی می شود. نوع درمان، یکی از مهمترین عوامل پیشگویی کننده اختلال عملکرد جنسی است که در سرطان های مختلف، متفاوت می باشد. مطالعه حاضر با هدف تعیین ارتباط اختلال عملکرد جنسی با نوع درمان در زنان مبتلا به سرطان های دستگاه تناسلی و پستان انجام شد.
روش کار: این مطالعه همبستگی در سال 1392 بر روی 150 زن مبتلا به سرطان های دستگاه تناسلی و پستان مراجعه کننده به بیمارستان های میلاد و سیدالشهداء شهر اصفهان انجام شد. واحد های پژوهش پرسشنامه های مشخصات فردی/ بیماری و پرسشنامه شاخص اختلال عملکرد جنسی و پرسشنامه اختلال عملکرد جنسی را تکمیل کردند. تجزیه و تحلیل داده ها با استفاده از نرم افزار آماری SPSS (نسخه 14) و آزمون های آماری تی دانشجویی و آنالیز واریانس یک طرفه انجام شد. میزان p کمتر از 05/0 معنی دار در نظر گرفته شد.
یافتهها: در این مطالعه 106 نفر (7/70%) از زنان سرطان پستان و 44 نفر (3/29%) سرطان ژنیکولوژیک داشتند. همچنین 71 نفر (3/47%) از بیماران، شیمی درمانی و رادیوترپی شده بودند. بر اساس آزمون آنالیز واریانس یک طرفه، اختلال عملکرد جنسی در گروه تحت درمان با رادیوتراپی و شیمی درمانی به طور معناداری بیشتر از بقیه گروه ها بود (002/0=p).
نتیجه گیری: در بیماران مبتلا به سرطان های پستان و دستگاه ژنیتال تحت درمان با رادیوتراپی و شیمی درمانی اختلال عملکرد جنسی بیشتر است.

کلیدواژه‌ها


عنوان مقاله [English]

Relationship between Sexual Dysfunction and Treatment Modality in Patients with Gynecologic and Breast Cancers

نویسندگان [English]

  • Fariba Fahami 1
  • Mitra Savabi 1
  • Soheila Mohamadirizi 2
  • Neyosha Shirani 3
1 M.Sc. in Midwifery, Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
2 M.Sc. in Midwifery, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
3 B.Sc. Student of Midwifery, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
چکیده [English]

Introduction: Sexual dysfunction refers to sexual desire disorders and psychosocial changes, which can impact one’s sexual response cycle and cause stress and interpersonal difficulties. Treatment modality is one of the most important predictive factors for sexual dysfunction and varies depending on the type of malignancy. The purpose of this study was to determine the relationship between sexual dysfunctions and treatment modality in gynecologic and breast cancer patients.
Methods: This correlational study was conducted on 150 women with gynecologic and breast cancers, referring to Seyedoshohada and Milad hospitals in Isfahan, Iran in 2011. The demographic/disease questionnaire, Female Sexual Function Index (FSFI), and Sexual function-Vaginal changes Questionnaire (SVQ) were completed by the subjects. Student’s t-test and one-way ANOVA were performed, using SPSS version 14. P-value less than 0.05 was considered statistically significant.
Results: As the results indicated, 106 (70.7%) and 44 (29.3%) women had breast and gynecologic cancers, respectively. Also, 71 (47.3%) patients had undergone radiotherapy and chemotherapy. According to ANOVA test results, Sexual dysfunction in patients treated with radiotherapy and chemotherapy was significantly greater than other groups (P=0.002).
Conclusion: Sexual dysfunction in patients with cancers of the breast and genital tract were treated with radiotherapy and chemotherapy was more.

کلیدواژه‌ها [English]

  • Cancer
  • Sexual function
  • Treatment
 
  1. Pinto AC. Sexuality and breast cancer: prime time for young patients. J Thorac Dis 2013;5(Suppl 1):S81-S86.
  2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60(5):277-300.
  3. Matulonis UA,  Kornblith A, Lee H, Bryan J, Gibson C, Wells C, et al. Long‐term adjustment of early‐stage ovarian cancer survivors. Int J Gynecol Cancer 2008;18(6):1183-93.
  4. Hopkinson JB, Fenlon DR, Okamoto I, Wright DN, Scott I, Addington-Hall JM, et al. The deliverability, acceptability, and perceived effect of the Macmillan approach to weight loss and eating difficulties: a phase II, cluster-randomized, exploratory trial of a psychosocial intervention for weight-and eating-related distress in people with advanced cancer. J Pain Symptom Manage 2010;40(5):684-95.
  5. Ismail KM. Psychological Challenges in Obstetrics and Gynecology. The Obstetrician & Gynaecologist. 2008;10(3):206.
  6. Anderson JL. Acknowledging Female Sexual Dysfunction in Women With Cancer. Clin J Oncol Nurs 2013;17(3):233-5.
  7. Rodin G, Olmsted MP, Rydall AC, Maharaj SI, Colton PA, Jones JM, et al. Eating disorders in young women with type 1 diabetes mellitus. J Psychosom Res 2002;53(4):943-9.
  8. Carter J, Huang H, Chase DM, Walker JL, Cella D, Wenzel L. Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 Study. Int J Gynecol Cancer. 2012;22(9):1624-33.
  9.  Collins JJ, Baase CM, Sharda CE, Ozminkowski RJ, Nicholson S, Billotti GM, et al. The assessment of chronic health conditions on work performance, absence, and total economic impact for employers. J Occup Environ Med 2005;47(6):547-57.
  10. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians. 2012;62(1):10-29.
  11. Plotti F, Nelaj E, Sansone M, Antonelli E, Altavilla T, Angioli R, et al. Sexual Function after Modified Radical Hysterectomy (Piver II/Type B) vs. Classic Radical Hysterectomy (Piver III/Type C2) for Early Stage Cervical Cancer. A Prospective Study. J Sex Med 2012;9(3):909-17.
  12. Emilee G, Ussher J, Perz J. Sexuality after breast cancer: a review. Maturitas 2010;66(4):397-407.
  13. Sbitti Y, Kadiri H, Essaidi I, Fadoukhair Z, Kharmoun S, Slimani K, et al. Breast cancer treatment and sexual dysfunction: Moroccan women's perception. BMC Womens Health 2011;11(1):29.
  14. Brotto LA, Yule M, Breckon E. Psychological interventions for the sexual sequelae of cancer: A review of the literature. J Cancer Surviv 2010;4(4):346-60.
  15. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 2005;23(30):7428-36.
  16. Bergmark K, ÅVallLundqvist E, Dickman PW, Henningsohn L, Steineck G. Patientrating of distressful symptoms after treatment for early cervicalcancer. Acta Obstet Gynecol Scand 2002;81(5):443-50.
  17. de Melo Ferreira AP, de Figueiredo EM, Lima RA, Cândido EB, de Castro Monteiro MV, de Figueiredo Franco TMR, et al. Quality of life in women with vulvar cancer submitted to surgical treatment: a comparative study. Eur J Obstet Gynecol Reprod Biol. 2012;165(1):91-5.
  18. Gershenson DM, Miller AM, Champion VL, Monahan PO, Zhao Q, Cella D, et al. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25(19):2792-7.
  19. Ratner ES, Foran K, Schwartz P, Minkin M. Sexuality and intimacy after gynecological cancer. Maturitas 2010; 66(1):23-6.
  20. Panjari M, Bell RJ, Davis SR. Sexual function after breast cancer. J Sex Med 2011;8(1):294-302.
  21. Forgione A, Leroy J, Cahill RA, Bailey C, Simone M, Mutter D, et al. Prospective evaluation of functional outcome after laparoscopic sigmoid colectomy. Ann Surg 2009;249(2):218-24.
  22. Brotto LA, Erskine Y, Carey M, Ehlen T, Finlayson S, Heywood M, et al. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer. Gynecol Oncol 2012;125(2):320-5.
  23. Akkuzu G, Ayhan A. Sexual Functions of Turkish Women with Gynecologic Cancer during the Chemotherapy Process. Asian Pac J Cancer Prev 2013;14(6):3561-4.
  24. Olsson C, Athlin E, Sandin‐Bojö AK, Larsson M. Sexuality is not a priority when disease and treatment side effects are severe: conceptions of patients with malignant blood diseases. J Clin Nurs 2013;22(23-24):3503-12.
  25. Zeighami Mohammadi S, Fatemeh G. Sexual Dysfunction and Its Correlation with Quality of Life among Women Affected with Cancer. The Iranian Journal of Obstetrics, Gynecology And Infertility 2009;12(2): 39-46.
  26. Hendren SK, O'Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005;242(2):212.
  27. Chen CP, Huang KG, Wan GH, Tu LY, Lee JT. Sexual satisfaction and related factors in women previously treated for gynecological cancer. Hu Li Za Zhi 2013;60(2):61-70.
  28. Binney GL. Sexual Satisfaction Among Young Breast Cancer Survivors. 2011.یافت نشد
  29. Yang EJ, Kim SW, Heo CY, Lim JY. Longitudinal changes in sexual problems related to cancer treatment in Korean breast cancer survivors: a prospective cohort study. Support Care Cancer 2011;19(7):909-18.
  30. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Earlystage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer 2004;100(1):97-106.
  31. Bakewell RT, Volker DL. Sexual dysfunction related to the treatment of young women with breast cancer. Clin J Oncol Nurs 2005;9(6):697-702.
  32. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2004;17(1):39-57.
  33. Moreira E, Brock G, Glasser D, Nicolosi A, Laumann E, Paik A, et al. Helpseeking behaviour for sexual problems: the Global Study of Sexual Attitudes and Behaviors. Int J Clin Pract 2005;59(1):6-16.